Determining the true burden of kidney stone disease

The incidence and prevalence of kidney stones have increased over the past four decades. However, the diagnosis of ‘kidney stone’ can range from an incidental asymptomatic finding of limited clinical significance to multiple painful episodes of ureteral obstruction with eventual kidney failure. Some...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Nephrology 2020-12, Vol.16 (12), p.736-746
Hauptverfasser: Thongprayoon, Charat, Krambeck, Amy E., Rule, Andrew D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 746
container_issue 12
container_start_page 736
container_title Nature reviews. Nephrology
container_volume 16
creator Thongprayoon, Charat
Krambeck, Amy E.
Rule, Andrew D.
description The incidence and prevalence of kidney stones have increased over the past four decades. However, the diagnosis of ‘kidney stone’ can range from an incidental asymptomatic finding of limited clinical significance to multiple painful episodes of ureteral obstruction with eventual kidney failure. Some general strategies may be useful to prevent the recurrence of kidney stones. In particular, greater attention to kidney stone classification, approaches to assessing the risk of recurrence and individualized prevention strategies may improve the clinical care of stone formers. Although there have been some advances in approaches to predicting the recurrence of kidney stones, notable challenges remain. Studies of kidney stone prevalence, incidence and recurrence have reported inconsistent findings, in part because of the lack of a standardized stone classification system. A kidney stone classification system based on practical and clinically useful measures of stone disease may help to improve both the study and clinical care of stone formers. Any future kidney stone classification system should be aimed at distinguishing asymptomatic from symptomatic stones, clinically diagnosed symptomatic stone episodes from self-reported symptomatic stone episodes, symptomatic stone episodes that are confirmed from those that are suspected, symptomatic recurrence from radiographic recurrence (that is, with radiographic evidence of a new stone, stone growth or stone disappearance from presumed passage) and determine stone composition based on mutually exclusive categories. Available data suggest that the prevalence and incidence of kidney stones is increasing; however, much of this variation might result from differences in approaches used to identify stone formers. This Review describes the need for a classification system to facilitate use of consistent terminology and enable meaningful comparisons of the burden of kidney stone disease across different populations. Key points Kidney stones can range from an asymptomatic incidental finding with limited clinical significance to a painful recurrent disorder with substantial morbidity. The prevalence and incidence of kidney stones has increased worldwide, but some of this increase is due to improvements in medical imaging with increased utilization of CT. Classifying stone formers according to their clinical presentation and stone composition can help to predict the risk of future symptomatic stone episodes and aid personalizat
doi_str_mv 10.1038/s41581-020-0320-7
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2430669443</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A641397201</galeid><sourcerecordid>A641397201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-8c9916cd33df7ce711b731c5c7cc2012c2487e4d279b750b95441185fb3a189f3</originalsourceid><addsrcrecordid>eNp1kU9r3DAQxUVpaP60H6CXYiiUXJxqLMljH0PStIVALi30Jmx5vKvUllJJPuTbR8tus01JEEiD9HvDPD3G3gM_Ay6az1GCaqDkFS-5yBu-YkeAqi0Vx1-vH-saDtlxjLec17VE9YYdigqVQMmPmLikRGG2zrpVkdZUpLBQ0S9hIFf4sfhtB0f3RUzeUTHYSF2kt-xg7KZI73bnCft59eXHxbfy-ubr94vz69JI5KlsTNtCbQYhhhENIUCPAowyaEzFoTKVbJDkUGHbo-J9q6QEaNTYiw6adhQn7HTb9y74PwvFpGcbDU1T58gvUVdSZEetlCKjH_9Db_0SXJ4uUwiqBkDYU6tuIm3d6FPozKapPq8liBbzXJk6e4bKa6DZmvwPo833TwSf_hGsqZvSOvppSda7-BSELWiCjzHQqO-Cnbtwr4HrTaJ6m6jOiepNohqz5sPO2dLPNDwq_kaYgWoLxPzkVhT21l_u-gCYH6Y1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471561171</pqid></control><display><type>article</type><title>Determining the true burden of kidney stone disease</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Thongprayoon, Charat ; Krambeck, Amy E. ; Rule, Andrew D.</creator><creatorcontrib>Thongprayoon, Charat ; Krambeck, Amy E. ; Rule, Andrew D.</creatorcontrib><description>The incidence and prevalence of kidney stones have increased over the past four decades. However, the diagnosis of ‘kidney stone’ can range from an incidental asymptomatic finding of limited clinical significance to multiple painful episodes of ureteral obstruction with eventual kidney failure. Some general strategies may be useful to prevent the recurrence of kidney stones. In particular, greater attention to kidney stone classification, approaches to assessing the risk of recurrence and individualized prevention strategies may improve the clinical care of stone formers. Although there have been some advances in approaches to predicting the recurrence of kidney stones, notable challenges remain. Studies of kidney stone prevalence, incidence and recurrence have reported inconsistent findings, in part because of the lack of a standardized stone classification system. A kidney stone classification system based on practical and clinically useful measures of stone disease may help to improve both the study and clinical care of stone formers. Any future kidney stone classification system should be aimed at distinguishing asymptomatic from symptomatic stones, clinically diagnosed symptomatic stone episodes from self-reported symptomatic stone episodes, symptomatic stone episodes that are confirmed from those that are suspected, symptomatic recurrence from radiographic recurrence (that is, with radiographic evidence of a new stone, stone growth or stone disappearance from presumed passage) and determine stone composition based on mutually exclusive categories. Available data suggest that the prevalence and incidence of kidney stones is increasing; however, much of this variation might result from differences in approaches used to identify stone formers. This Review describes the need for a classification system to facilitate use of consistent terminology and enable meaningful comparisons of the burden of kidney stone disease across different populations. Key points Kidney stones can range from an asymptomatic incidental finding with limited clinical significance to a painful recurrent disorder with substantial morbidity. The prevalence and incidence of kidney stones has increased worldwide, but some of this increase is due to improvements in medical imaging with increased utilization of CT. Classifying stone formers according to their clinical presentation and stone composition can help to predict the risk of future symptomatic stone episodes and aid personalization of stone prevention strategies. The wide range of recurrence rates reported between different studies might largely be due to the use of different definitions that include various degrees of symptomatic evidence of recurrence and/or radiographic manifestations of recurrence. Risk factors for symptomatic kidney stone recurrence include younger age, male gender, family history of stones, obesity, pregnancy, rarer stone compositions, higher radiographic kidney stone burden, number of past symptomatic kidney stone episodes and fewer years since last kidney stone episode.</description><identifier>ISSN: 1759-5061</identifier><identifier>EISSN: 1759-507X</identifier><identifier>DOI: 10.1038/s41581-020-0320-7</identifier><identifier>PMID: 32753740</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/499 ; 692/699/1585/273 ; Asymptomatic ; Asymptomatic Diseases ; Care and treatment ; Classification ; Cost of Illness ; Development and progression ; Evaluation ; Humans ; Incidence ; Kidney Calculi - chemistry ; Kidney Calculi - classification ; Kidney Calculi - diagnosis ; Kidney Calculi - etiology ; Kidney stones ; Medical research ; Medicine ; Medicine &amp; Public Health ; Medicine, Experimental ; Nephrology ; Practice guidelines (Medicine) ; Prognosis ; Recurrence ; Review Article ; Terminology</subject><ispartof>Nature reviews. Nephrology, 2020-12, Vol.16 (12), p.736-746</ispartof><rights>Springer Nature Limited 2020</rights><rights>COPYRIGHT 2020 Nature Publishing Group</rights><rights>Springer Nature Limited 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-8c9916cd33df7ce711b731c5c7cc2012c2487e4d279b750b95441185fb3a189f3</citedby><cites>FETCH-LOGICAL-c470t-8c9916cd33df7ce711b731c5c7cc2012c2487e4d279b750b95441185fb3a189f3</cites><orcidid>0000-0002-8313-3604 ; 0000-0001-8255-598X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32753740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thongprayoon, Charat</creatorcontrib><creatorcontrib>Krambeck, Amy E.</creatorcontrib><creatorcontrib>Rule, Andrew D.</creatorcontrib><title>Determining the true burden of kidney stone disease</title><title>Nature reviews. Nephrology</title><addtitle>Nat Rev Nephrol</addtitle><addtitle>Nat Rev Nephrol</addtitle><description>The incidence and prevalence of kidney stones have increased over the past four decades. However, the diagnosis of ‘kidney stone’ can range from an incidental asymptomatic finding of limited clinical significance to multiple painful episodes of ureteral obstruction with eventual kidney failure. Some general strategies may be useful to prevent the recurrence of kidney stones. In particular, greater attention to kidney stone classification, approaches to assessing the risk of recurrence and individualized prevention strategies may improve the clinical care of stone formers. Although there have been some advances in approaches to predicting the recurrence of kidney stones, notable challenges remain. Studies of kidney stone prevalence, incidence and recurrence have reported inconsistent findings, in part because of the lack of a standardized stone classification system. A kidney stone classification system based on practical and clinically useful measures of stone disease may help to improve both the study and clinical care of stone formers. Any future kidney stone classification system should be aimed at distinguishing asymptomatic from symptomatic stones, clinically diagnosed symptomatic stone episodes from self-reported symptomatic stone episodes, symptomatic stone episodes that are confirmed from those that are suspected, symptomatic recurrence from radiographic recurrence (that is, with radiographic evidence of a new stone, stone growth or stone disappearance from presumed passage) and determine stone composition based on mutually exclusive categories. Available data suggest that the prevalence and incidence of kidney stones is increasing; however, much of this variation might result from differences in approaches used to identify stone formers. This Review describes the need for a classification system to facilitate use of consistent terminology and enable meaningful comparisons of the burden of kidney stone disease across different populations. Key points Kidney stones can range from an asymptomatic incidental finding with limited clinical significance to a painful recurrent disorder with substantial morbidity. The prevalence and incidence of kidney stones has increased worldwide, but some of this increase is due to improvements in medical imaging with increased utilization of CT. Classifying stone formers according to their clinical presentation and stone composition can help to predict the risk of future symptomatic stone episodes and aid personalization of stone prevention strategies. The wide range of recurrence rates reported between different studies might largely be due to the use of different definitions that include various degrees of symptomatic evidence of recurrence and/or radiographic manifestations of recurrence. Risk factors for symptomatic kidney stone recurrence include younger age, male gender, family history of stones, obesity, pregnancy, rarer stone compositions, higher radiographic kidney stone burden, number of past symptomatic kidney stone episodes and fewer years since last kidney stone episode.</description><subject>692/499</subject><subject>692/699/1585/273</subject><subject>Asymptomatic</subject><subject>Asymptomatic Diseases</subject><subject>Care and treatment</subject><subject>Classification</subject><subject>Cost of Illness</subject><subject>Development and progression</subject><subject>Evaluation</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kidney Calculi - chemistry</subject><subject>Kidney Calculi - classification</subject><subject>Kidney Calculi - diagnosis</subject><subject>Kidney Calculi - etiology</subject><subject>Kidney stones</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Medicine, Experimental</subject><subject>Nephrology</subject><subject>Practice guidelines (Medicine)</subject><subject>Prognosis</subject><subject>Recurrence</subject><subject>Review Article</subject><subject>Terminology</subject><issn>1759-5061</issn><issn>1759-507X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kU9r3DAQxUVpaP60H6CXYiiUXJxqLMljH0PStIVALi30Jmx5vKvUllJJPuTbR8tus01JEEiD9HvDPD3G3gM_Ay6az1GCaqDkFS-5yBu-YkeAqi0Vx1-vH-saDtlxjLec17VE9YYdigqVQMmPmLikRGG2zrpVkdZUpLBQ0S9hIFf4sfhtB0f3RUzeUTHYSF2kt-xg7KZI73bnCft59eXHxbfy-ubr94vz69JI5KlsTNtCbQYhhhENIUCPAowyaEzFoTKVbJDkUGHbo-J9q6QEaNTYiw6adhQn7HTb9y74PwvFpGcbDU1T58gvUVdSZEetlCKjH_9Db_0SXJ4uUwiqBkDYU6tuIm3d6FPozKapPq8liBbzXJk6e4bKa6DZmvwPo833TwSf_hGsqZvSOvppSda7-BSELWiCjzHQqO-Cnbtwr4HrTaJ6m6jOiepNohqz5sPO2dLPNDwq_kaYgWoLxPzkVhT21l_u-gCYH6Y1</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Thongprayoon, Charat</creator><creator>Krambeck, Amy E.</creator><creator>Rule, Andrew D.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8313-3604</orcidid><orcidid>https://orcid.org/0000-0001-8255-598X</orcidid></search><sort><creationdate>20201201</creationdate><title>Determining the true burden of kidney stone disease</title><author>Thongprayoon, Charat ; Krambeck, Amy E. ; Rule, Andrew D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-8c9916cd33df7ce711b731c5c7cc2012c2487e4d279b750b95441185fb3a189f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>692/499</topic><topic>692/699/1585/273</topic><topic>Asymptomatic</topic><topic>Asymptomatic Diseases</topic><topic>Care and treatment</topic><topic>Classification</topic><topic>Cost of Illness</topic><topic>Development and progression</topic><topic>Evaluation</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kidney Calculi - chemistry</topic><topic>Kidney Calculi - classification</topic><topic>Kidney Calculi - diagnosis</topic><topic>Kidney Calculi - etiology</topic><topic>Kidney stones</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Medicine, Experimental</topic><topic>Nephrology</topic><topic>Practice guidelines (Medicine)</topic><topic>Prognosis</topic><topic>Recurrence</topic><topic>Review Article</topic><topic>Terminology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thongprayoon, Charat</creatorcontrib><creatorcontrib>Krambeck, Amy E.</creatorcontrib><creatorcontrib>Rule, Andrew D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thongprayoon, Charat</au><au>Krambeck, Amy E.</au><au>Rule, Andrew D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determining the true burden of kidney stone disease</atitle><jtitle>Nature reviews. Nephrology</jtitle><stitle>Nat Rev Nephrol</stitle><addtitle>Nat Rev Nephrol</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>16</volume><issue>12</issue><spage>736</spage><epage>746</epage><pages>736-746</pages><issn>1759-5061</issn><eissn>1759-507X</eissn><abstract>The incidence and prevalence of kidney stones have increased over the past four decades. However, the diagnosis of ‘kidney stone’ can range from an incidental asymptomatic finding of limited clinical significance to multiple painful episodes of ureteral obstruction with eventual kidney failure. Some general strategies may be useful to prevent the recurrence of kidney stones. In particular, greater attention to kidney stone classification, approaches to assessing the risk of recurrence and individualized prevention strategies may improve the clinical care of stone formers. Although there have been some advances in approaches to predicting the recurrence of kidney stones, notable challenges remain. Studies of kidney stone prevalence, incidence and recurrence have reported inconsistent findings, in part because of the lack of a standardized stone classification system. A kidney stone classification system based on practical and clinically useful measures of stone disease may help to improve both the study and clinical care of stone formers. Any future kidney stone classification system should be aimed at distinguishing asymptomatic from symptomatic stones, clinically diagnosed symptomatic stone episodes from self-reported symptomatic stone episodes, symptomatic stone episodes that are confirmed from those that are suspected, symptomatic recurrence from radiographic recurrence (that is, with radiographic evidence of a new stone, stone growth or stone disappearance from presumed passage) and determine stone composition based on mutually exclusive categories. Available data suggest that the prevalence and incidence of kidney stones is increasing; however, much of this variation might result from differences in approaches used to identify stone formers. This Review describes the need for a classification system to facilitate use of consistent terminology and enable meaningful comparisons of the burden of kidney stone disease across different populations. Key points Kidney stones can range from an asymptomatic incidental finding with limited clinical significance to a painful recurrent disorder with substantial morbidity. The prevalence and incidence of kidney stones has increased worldwide, but some of this increase is due to improvements in medical imaging with increased utilization of CT. Classifying stone formers according to their clinical presentation and stone composition can help to predict the risk of future symptomatic stone episodes and aid personalization of stone prevention strategies. The wide range of recurrence rates reported between different studies might largely be due to the use of different definitions that include various degrees of symptomatic evidence of recurrence and/or radiographic manifestations of recurrence. Risk factors for symptomatic kidney stone recurrence include younger age, male gender, family history of stones, obesity, pregnancy, rarer stone compositions, higher radiographic kidney stone burden, number of past symptomatic kidney stone episodes and fewer years since last kidney stone episode.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32753740</pmid><doi>10.1038/s41581-020-0320-7</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-8313-3604</orcidid><orcidid>https://orcid.org/0000-0001-8255-598X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1759-5061
ispartof Nature reviews. Nephrology, 2020-12, Vol.16 (12), p.736-746
issn 1759-5061
1759-507X
language eng
recordid cdi_proquest_miscellaneous_2430669443
source MEDLINE; Alma/SFX Local Collection
subjects 692/499
692/699/1585/273
Asymptomatic
Asymptomatic Diseases
Care and treatment
Classification
Cost of Illness
Development and progression
Evaluation
Humans
Incidence
Kidney Calculi - chemistry
Kidney Calculi - classification
Kidney Calculi - diagnosis
Kidney Calculi - etiology
Kidney stones
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Nephrology
Practice guidelines (Medicine)
Prognosis
Recurrence
Review Article
Terminology
title Determining the true burden of kidney stone disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T01%3A00%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determining%20the%20true%20burden%20of%20kidney%20stone%20disease&rft.jtitle=Nature%20reviews.%20Nephrology&rft.au=Thongprayoon,%20Charat&rft.date=2020-12-01&rft.volume=16&rft.issue=12&rft.spage=736&rft.epage=746&rft.pages=736-746&rft.issn=1759-5061&rft.eissn=1759-507X&rft_id=info:doi/10.1038/s41581-020-0320-7&rft_dat=%3Cgale_proqu%3EA641397201%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2471561171&rft_id=info:pmid/32753740&rft_galeid=A641397201&rfr_iscdi=true